Compare GIFT & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIFT | CPHI |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0M | 25.3M |
| IPO Year | 2019 | 2008 |
| Metric | GIFT | CPHI |
|---|---|---|
| Price | $0.54 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 345.6K | ★ 1.1M |
| Earning Date | 11-03-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.05 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $83,181,716.00 | $4,144,268.00 |
| Revenue This Year | $6.02 | N/A |
| Revenue Next Year | $8.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.39 | $0.38 |
| 52 Week High | $1.29 | $19.19 |
| Indicator | GIFT | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | 39.24 |
| Support Level | $0.42 | $0.53 |
| Resistance Level | $0.75 | $0.68 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 41.95 | 22.48 |
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.